Differential Diagnoses: Early Morning Hypoglycemia + Myoclonic Jerks on Waking in a 10-Year-Old Girl (6-month history, no diabetes)

• Two separate but co-existing conditions, OR
• A single unifying diagnosis where hypoglycemia triggers/unmasks seizures, OR
• A metabolic epilepsy syndrome where both stem from the same root cause

TIER 1 - Top Differential: Most Likely

1. Juvenile Myoclonic Epilepsy (JME)

• Onset typically 10-25 years, but can start at age 10
• Myoclonic jerks characteristically occur in the morning shortly after waking, often involving arms/shoulders - dropping cups, spilling drinks
• Normal intelligence, no structural brain disease
• EEG: 4-6 Hz polyspike-wave discharges, most prominent in the morning
• Can progress to generalized tonic-clonic seizures
• However: JME does not itself cause hypoglycemia. The hypoglycemia here would need a separate explanation (fasting overnight, skipping dinner, or a separate metabolic issue)
• Key question: Is the hypoglycemia causing/triggering the jerks, or are they independent?

2. Hypoglycemia-Induced Seizures / Myoclonus (Symptomatic Myoclonus)

• Clumsy/jerky movements are a classic symptom of hypoglycemia in children
• Can progress to seizures, altered consciousness, or coma
• The early morning timing fits perfectly: prolonged overnight fast depletes glycogen stores by morning
• This is especially relevant if the child eats an early dinner or skips snacks
• The myoclonic jerks here would be symptomatic/metabolic myoclonus, not epileptic in origin
• Would respond to glucose normalization

TIER 2 - Metabolic Causes of Hypoglycemia (Explaining the Hypoglycemia)

3. Idiopathic Ketotic Hypoglycemia (IKH)

• Most common cause of recurrent hypoglycemia in non-diabetic children aged 18 months to 7 years - but can persist toward age 10
• Typically resolves by ~9 years (this child is right at the edge)
• Occurs in the morning after overnight fasting - classic timing
• Mechanism: limited glycogen stores + inadequate gluconeogenesis substrate (alanine)
• Associated with high ketones (ketotic), low insulin
• Diagnosis of exclusion
• IKH + coincident JME is entirely possible

4. Growth Hormone (GH) Deficiency

• GH is a key counter-regulatory hormone; deficiency impairs fasting glucose maintenance
• Presents with morning hypoglycemia (GH surge is normally overnight/early morning)
• Look for: short stature, slow growth velocity, midline defects
• Can cause seizures secondary to hypoglycemia

5. Cortisol Deficiency (Adrenal Insufficiency / ACTH Deficiency)

• Cortisol is the other major counter-regulatory hormone
• Deficiency leads to fasting hypoglycemia, especially in the morning when cortisol levels are normally rising
• Associated with fatigue, poor appetite, hyperpigmentation (primary AI) or pallor (central AI)
• Can cause seizures via hypoglycemia

6. Glycogen Storage Disease (GSD) - particularly GSD Type I (von Gierke) or Type III

• Impaired glycogenolysis or gluconeogenesis
• Can present with fasting hypoglycemia in children
• GSD Type I: hepatomegaly, lactic acidosis, hyperlipidemia, fasting hypoglycemia
• GSD Type III: milder, hepatomegaly, myopathy possible
• Often presents earlier in life, but milder forms can present later

7. Fatty Acid Oxidation Disorders (e.g., MCAD deficiency)

• Impaired ketone synthesis during fasting
• Hypoketotic hypoglycemia - low or inappropriately normal ketones
• Typically precipitated by fasting or illness
• Can cause cardiomyopathy and liver disease in addition to CNS effects

TIER 3 - Epileptic Syndromes with Both Features

8. GLUT1 Deficiency Syndrome (Glucose Transporter 1 Deficiency)

• Important and under-recognized
• GLUT1 transports glucose across the blood-brain barrier; deficiency starves the brain of glucose even with normal blood glucose
• Key feature: symptoms worse in the morning (fasting state), improve after eating
• Presents with: seizures, myoclonus, ataxia, cognitive issues
• Classic finding: low CSF glucose with normal blood glucose (CSF:blood glucose ratio <0.4)
• Myoclonic epilepsy is a recognized phenotype
• Onset typically in infancy but milder forms can present in childhood/adolescence
• Ketogenic diet is highly effective treatment
• A published case report has specifically noted GLUT1 deficiency presenting with opsoclonus and epileptic myoclonus

9. Doose Syndrome (Myoclonic-Atonic Epilepsy)

• Onset typically 2-6 years but can extend into this age range
• Myoclonic seizures + atonic seizures (drop attacks)
• Normal development initially, may have cognitive regression
• Not directly associated with hypoglycemia

10. Progressive Myoclonic Epilepsy (PME) - Unverricht-Lundborg, Lafora, NCL

• More ominous diagnoses to exclude
• Characterized by: myoclonus + progressive neurological deterioration
• Lafora disease: onset 8-18 years, action myoclonus, visual hallucinations, dementia
• Neuronal Ceroid Lipofuscinosis (NCL): visual loss, cognitive decline
• 6-month history is relatively short - watch for progression

TIER 4 - Other Considerations

Key Distinguishing Workup

1. Critical sample during hypoglycemic episode: glucose, insulin, C-peptide, cortisol, GH, beta-hydroxybutyrate, free fatty acids, lactate, ammonia, amino acids
2. Ketones: high = ketotic (GSD III, IKH, cortisol/GH deficiency); low/absent = hypoketotic (hyperinsulinism, fatty acid oxidation disorders, GSD I)
3. Insulin level: if inappropriately elevated - consider insulinoma or exogenous insulin
4. Morning cortisol + stimulation test (short Synacthen)
5. IGF-1, IGF-BP3, GH stimulation test
6. Liver enzymes, lactate (GSD workup)
7. Plasma acylcarnitine profile + urine organic acids (fatty acid oxidation disorders)

1. EEG - ideally morning EEG (most sensitive for JME): look for 4-6 Hz polyspike-wave
2. MRI brain - rule out structural causes, Lafora bodies not visible on MRI
3. CSF glucose and lactate - if GLUT1 is suspected (CSF:blood glucose ratio)
4. Genetic panel - GLUT1 (SLC2A1), progressive myoclonic epilepsy genes if progressive features

Clinical Bottom Line

GLUT1 deficiency - brain glucose starvation worsened by fasting (mornings), producing epileptic myoclonus on waking, with the blood glucose appearing low or borderline because the brain is extracting glucose maximally. Check the CSF:blood glucose ratio.

1. Symptomatic myoclonus from hypoglycemia (the jerks are a consequence of low glucose)
2. JME + coincident ketotic/IKH hypoglycemia (two separate diagnoses)
3. GH or cortisol deficiency causing the morning hypoglycemia

Refined Differentials: Detectable Insulin During Hypoglycemia + Normal Cortisol

Any detectable insulin level during hypoglycemia is abnormal. Normally, insulin should be completely suppressed (often undetectable) when blood glucose falls. A detectable level - even if within the "normal fasting range" - is inappropriately elevated and confirms hyperinsulinemic hypoglycemia (HH).

Revised Differential Diagnoses (Hyperinsulinism-Focused)

TOP PRIORITY

1. Congenital Hyperinsulinism (CHI) - Late-Onset / Attenuated Form

• CHI is the most common cause of persistent/recurrent hyperinsulinemic hypoglycemia in children
• Classic presentation is neonatal, but late-onset forms exist in 0.5-5% of cases - presenting in childhood or adolescence
• The child has had symptoms for only 6 months, suggesting possible late-onset genetic CHI
• Genetic mutations in at least 15 identified genes: most commonly ABCC8 and KCNJ11 (encoding the KATP channel subunits SUR1 and Kir6.2), and also GLUD1, GCK, HADH, HNF1A, HNF4A, HK1
• Biochemical hallmark: low/suppressed ketone bodies and free fatty acids at the time of hypoglycemia (because insulin actively suppresses lipolysis and ketogenesis)
• Can have focal (surgically correctable) or diffuse (requires medical/near-total pancreatectomy) disease
• Seizures are a major presenting feature - hypoglycemia-induced neuroglycopenia causes the early morning convulsions/myoclonic jerks seen here

2. Hyperinsulinism/Hyperammonemia Syndrome (HI/HA - GLUD1 Mutation)

• Caused by activating mutations in GLUD1 (glutamate dehydrogenase gene)
• Produces both fasting AND protein-induced hypoglycemia (leucine-sensitive)
• Key distinguishing feature: persistently elevated ammonia (usually 3-5x upper limit of normal), asymptomatic
• Seizures - including myoclonic and absence-type epilepsy - are reported in 30-50% of HI/HA patients, often independently of hypoglycemic episodes (epilepsy may be a direct consequence of the GDH enzyme defect in the brain)
• This syndrome fits the clinical picture remarkably well: morning hypoglycemia + epileptic myoclonus + childhood onset
• Check: fasting and post-protein-load ammonia levels

3. Insulinoma

• Insulin-secreting pancreatic beta-cell tumor
• Rare in pediatric age group (most insulinomas occur in adults), but can occur in children aged 5-15 years
• Classic Whipple's triad: (a) symptoms during fasting/activity, (b) blood glucose <40-50 mg/dL, (c) relief with glucose administration
• Associated with MEN1 syndrome (multiple endocrine neoplasia type 1) - check for family history of panhypopituitarism, gastrinoma, hyperparathyroidism
• Imaging: CT/MRI pancreas for localization; endoscopic ultrasound is most sensitive; 18F-DOPA PET-CT if CHI not excluded
• C-peptide will be elevated (unlike exogenous insulin administration)

4. Exogenous Insulin Administration (Factitious Hypoglycemia / Munchausen by Proxy)

• Surreptitious insulin administration by the child herself or a caregiver
• Gives the same biochemical picture as endogenous hyperinsulinism
• Key distinguishing test: C-peptide level
  • Exogenous insulin: insulin elevated, C-peptide suppressed (exogenous insulin has no C-peptide; it also suppresses endogenous secretion)
  • Endogenous hyperinsulinism: both insulin AND C-peptide elevated
• Also check for proinsulin (elevated in insulinoma and CHI, suppressed with exogenous insulin)
• Urine/serum sulfonylurea screen - these drugs stimulate endogenous insulin secretion, so C-peptide would be elevated (unlike injected insulin)

5. Sulfonylurea Ingestion / Poisoning

• Access to a family member's diabetic medications?
• Stimulates endogenous insulin secretion → both insulin AND C-peptide elevated
• Differentiates from exogenous insulin injection (where C-peptide is low)
• Urine toxicology screen for sulfonylureas is mandatory

6. GCK (Glucokinase) Activating Mutation

• Activating mutations in the glucokinase gene lower the threshold for glucose-stimulated insulin secretion
• Beta cells "sense" glucose as high even at normal levels, secreting insulin inappropriately
• Presents with mild to moderate fasting hypoglycemia, often picked up incidentally or in childhood
• Diazoxide-responsive
• Autosomal dominant - check family history for hypoglycemia

7. HNF1A / HNF4A Mutations (MODY-related hyperinsulinism)

• Mutations in hepatocyte nuclear factor genes can cause neonatal or childhood hyperinsulinism that later transitions to diabetes in adulthood (MODY 1/3)
• The hyperinsulinemic phase can last months to years
• Diazoxide-responsive
• Family history: relatives with diabetes diagnosed before age 25, often slim, no insulin resistance

Diagnostic Framework for This Child

Step 1 - Confirm hyperinsulinism subtype with critical sample (at the time of hypoglycemia):

Step 2 - If C-peptide elevated (endogenous):

• Sulfonylurea screen (urine/blood)
• Ammonia (HI/HA)
• Genetic panel: ABCC8, KCNJ11, GLUD1, GCK, HNF1A, HNF4A, HADH
• Diazoxide trial (if KATP channel defect - most CHI is diazoxide-responsive; ABCC8/KCNJ11 focal/diffuse disease may be resistant)

Step 3 - Imaging if genetic cause not found:

• 18F-DOPA PET-CT: gold standard for differentiating focal vs. diffuse CHI and for localizing insulinoma
• MRI pancreas + EUS (endoscopic ultrasound) for insulinoma

Step 4 - Address the seizures:

• Are the myoclonic jerks purely hypoglycemic (will resolve with glucose normalization)?
• Or independent epilepsy? - EEG, especially morning EEG
• In HI/HA (GLUD1), epilepsy can be independent of glucose levels and may need antiseizure medication

Bottom Line for This Child